Volume 1 Issue 3
Sep.  2017
Turn off MathJax
Article Contents
Abstract
Related Articles
Zequn Zheng, Qi Tang, Zhenqing Feng. CAR-T cell therapy and its application in clinical cancer treatment[J]. Blood&Genomics, 2017, 1(3): 1-6. DOI: 10.46701/APJBG.2017032017040
Citation: Zequn Zheng, Qi Tang, Zhenqing Feng. CAR-T cell therapy and its application in clinical cancer treatment[J]. Blood&Genomics, 2017, 1(3): 1-6. DOI: 10.46701/APJBG.2017032017040
shu

CAR-T cell therapy and its application in clinical cancer treatment

  • Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University, Nanjing, Jiangsu, 211166, China

More Information
  • Available Online: 2021-06-29
    Graphical Abstract
    • Abstract
  • Immunotherapy is regarded as the most significant method for cancer treatment in recent years. Chimeric antigen receptor T cells (CAR-T) technology, one form of target immunotherapy, has made a great breakthrough in hematological malignancies treatment and also a few progress in solid tumor treatment. This article reviews the history and mechanism of CAR-T, as well as the advantages and limitations of CAR-T in clinical cancer treatment. Then the review mainly discussed the clinical trial progress of CAR-T cell therapy in solid tumor treatment. A primary obstacle of CAR-T therapy is the heterogeneity in solid tumors. With an increasing number of solid tumor surface antigens being discovered, different varieties of CARs have been designed to treat solid tumors and have made some progress in clinical trial. In the end, this review puts forward a possible development direction of CAR-T.
    • FullText(HTML)
    • References (0)
    • Related Articles

  • Related Articles

    [1]Caidong Hu, Xiaofeng Luo, Na Xian, Chenjing Ye, Guolin Hu, Jinhua Ren, Xiaoyun Zheng, Jing Li, Xiaozhu Yang, Hao Zheng, Yongzhi Zheng, Zhongchao Han, Gangxiong Huang, Jianda Hu, Ting Yang. Induction of Cytokine Storm with Organ Dysfunction and Ineffective Response to Tocilizumab and Steroids by CAR-T Cell Therapy is Rescued by Mesenchymal Stem Cells: A Case Report[J]. Blood&Genomics, 2024, 8(1): 10006. DOI: 10.70322/BG20240110006
    [2]Yuxuan Huang, Hongbiao Shen, Qi Tang. Research and progress of CAR-macrophage cell therapy for solid tumors[J]. Blood&Genomics, 2023, 7(2): 86-93. DOI: 10.46701/BG.2023022023020
    [3]Jikai He, Jiaqi Jia, Wenhao Qu, Lizhou Jia, Wei Zhao. The function and regulatory mechanism of B cells in tumor immunity[J]. Blood&Genomics, 2022, 6(2): 103-113. DOI: 10.46701/BG.2022022022031
    [4]Wenwen Zhao, Weiyu Kong, Yan Peng, Qi Tang, Zhenqing Feng. The progress of research on chimeric antigen receptor NK cells[J]. Blood&Genomics, 2022, 6(2): 91-101. DOI: 10.46701/BG.2022022022027
    [5]Yan Peng, Zhenqing Feng. The progress and perspectives of CAR-T cell therapy[J]. Blood&Genomics, 2021, 5(2): 107-111. DOI: 10.46701/BG.2021022021126
    [6]Guosheng Su, Yesheng Wei, Lihua Qin, Lida Mo. A dynamic analysis of viral load, T lymphocyte subsets and main biochemical indexes before and after prevention of mother to child transmission (PMTCT) in HIV/AIDS[J]. Blood&Genomics, 2018, 2(4): 223-231. DOI: 10.46701/APJBG.2018042018128
    [7]Xuan Gu, Qi Tang. Tumor immune microenvironment: sanctuary of tumor and target for immunotherapy[J]. Blood&Genomics, 2018, 2(3): 141-148. DOI: 10.46701/APJBG.2018032018125
    [8]Zhenqing Feng. Current situation and prospect of individualized oncology medicine in precision medicine[J]. Blood&Genomics, 2017, 1(4): 1-2. DOI: 10.46701/APJBG.2017042017046
    [9]Yaru Xu, Qi Tang, Xiaochen Huang, Tingting Yang, Wei Zhao, Xingwan Kuai, Jin Zhu. Trop-2 targeted CAR-T cells inflict enhanced killing of ovarian cancer cells[J]. Blood&Genomics, 2017, 1(3): 19-24. DOI: 10.46701/APJBG.2017032017037
    [10]Weixin Zhou, Yuanshuai Huang. Blood salvage, proper choice for tumor patients?[J]. Blood&Genomics, 2017, 1(2): 1-5. DOI: 10.46701/APJBG.20170217019

  • Cited by

    Periodical cited type(2)

    1. Rahul Nath Choudhury. Mapping Chinese Investment in South Asia. 2023. DOI:10.1007/978-981-99-1385-5
    2. Jiaojiao Guo, Qi Tang. Recent updates on chimeric antigen receptor T cell therapy for hepatocellular carcinoma. Cancer Gene Therapy, 2021, 28(10-11): 1075-1087. DOI:10.1038/s41417-020-00259-4

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1532) PDF downloads (1191) Cited by(2)
    Related

    Copyright © Blood and Genomics苏公网安备 32028102000501号苏ICP备14047883号-6

    Address：Rooms 1318-19, Hollywood Plaza, 610 Nathan Road, Mongkok, Kowloon, HongKong

    E-mail：editorial_office@apjbg.com

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return